Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
MGZ Medical Genetics Center | RCV002289375 | SCV002580196 | pathogenic | Developmental and epileptic encephalopathy, 5 | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004047607 | SCV004956298 | uncertain significance | Inborn genetic diseases | 2024-02-29 | criteria provided, single submitter | clinical testing | The c.6896_6904delGGGACCAGC (p.W2299_Q2301del) alteration, located in coding exon 52 of the SPTAN1 gene, results from an in-frame deletion of 9 nucleotides at positions c.6896 to c.6904. This results in the deletion of 3 amino acids between codons 2299 and 2301. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). These amino acid positions are highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis (Choi, 2012). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |